2020 quarterly periods ended | Year ended | Quarter ended 2021 | ||||||||||||||||||||||||||||||||||||
March 31 | June 30 | September 30 | December 31 | December 31, 2020 | March 31 | |||||||||||||||||||||||||||||||||
Diluted earnings (loss) per share, as reported | $ | 0.30 | $ | (0.36) | $ | (2.32) | $ | 0.54 | $ | (1.83) | $ | 0.30 | ||||||||||||||||||||||||||
Dilutive impact (1) | — | — | 0.01 | 0.01 | — | |||||||||||||||||||||||||||||||||
Special Items to consider in evaluating quality of EPS: | ||||||||||||||||||||||||||||||||||||||
Impairment of goodwill and indefinite-lived intangible assets | — | — | 3.08 | — | 3.07 | — | ||||||||||||||||||||||||||||||||
Change in accounting policy for asbestos-related costs | — | 0.54 | — | — | 0.53 | — | ||||||||||||||||||||||||||||||||
Business restructuring and severance costs | 0.02 | 0.45 | 0.01 | 0.04 | 0.52 | 0.10 | ||||||||||||||||||||||||||||||||
Purchase accounting costs | 0.01 | 0.05 | — | — | 0.06 | 0.02 | ||||||||||||||||||||||||||||||||
M&A diligence and transaction costs | 0.02 | 0.01 | 0.02 | 0.02 | 0.07 | 0.01 | ||||||||||||||||||||||||||||||||
Pre-acquisition contingent liability | — | — | 0.05 | — | 0.05 | — | ||||||||||||||||||||||||||||||||
Change in recognized tax benefits | — | — | — | (0.20) | (0.20) | — | ||||||||||||||||||||||||||||||||
Income tax effect of Special Items(2) | (0.01) | (0.26) | (0.42) | (0.02) | (0.71) | (0.03) | ||||||||||||||||||||||||||||||||
Pre-tax amortization of acquisition-related intangible assets | 0.11 | 0.12 | 0.12 | 0.12 | 0.47 | 0.12 | ||||||||||||||||||||||||||||||||
Income tax benefit on amortization of acquisition-related intangible assets(2) | (0.03) | (0.03) | (0.03) | (0.03) | (0.12) | (0.03) | ||||||||||||||||||||||||||||||||
Adjusted diluted EPS | $ | 0.42 | $ | 0.52 | $ | 0.52 | $ | 0.47 | $ | 1.92 | $ | 0.49 | ||||||||||||||||||||||||||
Weighted-average shares outstanding (1) | 44,470,472 | 43,648,211 | 43,672,026 | 43,493,781 | 43,821,123 | 43,634,876 | ||||||||||||||||||||||||||||||||